Related Experiment Videos
Modifying role of vitamins on the mutagenic action of N-methyl-N'-nitro-N-nitrosoguanidine
T K Shetty1, A R Francis, R K Bhattacharya
1Biochemistry Division, Bhabha Atomic Research Centre, Bombay, India.
Abstract:
Several vitamin compounds have been tested for their ability to suppress the mutagenicity of N-methyl-N'-nitro-N-nitrosoguanidine, a direct acting mutagen/carcinogen, in Salmonella typhimurium strain TA100. Menadione, alpha-tocopherol, retinal and retinol have displayed high inhibitory activity. The antimutagenic activity of menadione, in particular, has been found to be remarkable in as much as less than equimolar amount can reduce the mutagenic potency of the carcinogen by 50%. In vitro data suggest that its action is mediated by accelerating the deactivation of the N-nitroso carcinogen, possibly involving the formation of a quinone radical.
Insights
Menadione and other vitamin compounds show strong antimutagenic effects against N-methyl-N'-nitro-N-nitrosoguanidine. Menadione is particularly effective, rapidly reducing carcinogen potency through accelerated deactivation.
Area of Science:
- Biochemistry
- Toxicology
- Nutritional Science
Background:
- Mutagenicity poses a significant health risk, necessitating the identification of compounds that can inhibit carcinogenic processes.
- N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) is a potent direct-acting mutagen and carcinogen.
- Investigating natural compounds for antimutagenic properties is crucial for developing preventative strategies.
Purpose of the Study:
- To evaluate the antimutagenic potential of various vitamin compounds against MNNG-induced mutagenicity.
- To specifically assess the efficacy of menadione as an inhibitor of MNNG's mutagenic activity.
- To elucidate the mechanism underlying menadione's antimutagenic action.
Main Methods:
- Utilized Salmonella typhimurium strain TA100 for mutagenicity testing.
- Screened several vitamin compounds, including menadione, alpha-tocopherol, retinal, and retinol, for their ability to suppress MNNG mutagenicity.
- Quantified the inhibitory activity and determined the effective concentration of menadione.
Main Results:
- Menadione, alpha-tocopherol, retinal, and retinol demonstrated significant suppression of MNNG mutagenicity.
- Menadione exhibited remarkable antimutagenic activity, reducing MNNG's potency by 50% at less than equimolar concentrations.
- In vitro studies suggest menadione accelerates MNNG deactivation, potentially via quinone radical formation.
Conclusions:
- Vitamin compounds, especially menadione, possess potent antimutagenic properties against direct-acting carcinogens like MNNG.
- Menadione's rapid deactivation of MNNG suggests a promising therapeutic or preventative role.
- Further research into menadione's mechanism could lead to novel strategies for cancer prevention.